Immunic Inc (IMUX)
1.25
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
1.25
0.00 (0.00%)
After-Hours: 20:00
Immunic Enterprise Value: 14.84M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 17, 2024 | 14.84M |
May 16, 2024 | 15.29M |
May 15, 2024 | 19.34M |
May 14, 2024 | 17.99M |
May 13, 2024 | 15.74M |
May 10, 2024 | 17.09M |
May 09, 2024 | 14.39M |
May 08, 2024 | 17.09M |
May 07, 2024 | 27.00M |
May 06, 2024 | 23.39M |
May 03, 2024 | 26.10M |
May 02, 2024 | 22.49M |
May 01, 2024 | 19.79M |
April 30, 2024 | 16.19M |
April 29, 2024 | 13.49M |
April 26, 2024 | 12.58M |
April 25, 2024 | 16.19M |
April 24, 2024 | 14.39M |
April 23, 2024 | 14.39M |
April 22, 2024 | 13.49M |
April 19, 2024 | 8.981M |
April 18, 2024 | 17.09M |
April 17, 2024 | 11.68M |
April 16, 2024 | 17.99M |
April 15, 2024 | 20.69M |
Date | Value |
---|---|
April 12, 2024 | 32.40M |
April 11, 2024 | 28.80M |
April 10, 2024 | 27.90M |
April 09, 2024 | 18.89M |
April 08, 2024 | 18.89M |
April 05, 2024 | 17.99M |
April 04, 2024 | 13.49M |
April 03, 2024 | 12.58M |
April 02, 2024 | 12.58M |
April 01, 2024 | 25.20M |
March 28, 2024 | 72.03M |
March 27, 2024 | 70.23M |
March 26, 2024 | 68.44M |
March 25, 2024 | 70.23M |
March 22, 2024 | 72.03M |
March 21, 2024 | 73.83M |
March 20, 2024 | 77.43M |
March 19, 2024 | 72.03M |
March 18, 2024 | 71.13M |
March 15, 2024 | 71.13M |
March 14, 2024 | 70.23M |
March 13, 2024 | 72.93M |
March 12, 2024 | 75.63M |
March 11, 2024 | 81.92M |
March 08, 2024 | 90.92M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-63.31M
Minimum
Jan 05 2023
408.10M
Maximum
Feb 16 2021
98.84M
Average
79.90M
Median
May 18 2022
Enterprise Value Benchmarks
Kymera Therapeutics Inc | 1.624B |
Insmed Inc | 4.248B |
SELLAS Life Sciences Group Inc | 65.91M |
Skye Bioscience Inc | 259.48M |
Leap Therapeutics Inc | 45.71M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -29.58M |
Total Expenses (Quarterly) | 23.88M |
EPS Diluted (Quarterly) | -0.30 |
Earnings Yield | -147.0% |